China SXT Pharmaceuticals (SXTC) Current Leases: 2023-2025
Historic Current Leases for China SXT Pharmaceuticals (SXTC) over the last 3 years, with Mar 2025 value amounting to $61,229.
- China SXT Pharmaceuticals' Current Leases fell 0.11% to -$34,776 in Q3 2025 from the same period last year, while for Sep 2025 it was -$34,776, marking a year-over-year decrease of 0.11%. This contributed to the annual value of $61,229 for FY2025, which is 5.01% up from last year.
- As of FY2025, China SXT Pharmaceuticals' Current Leases stood at $61,229, which was up 5.01% from $58,310 recorded in FY2024.
- In the past 5 years, China SXT Pharmaceuticals' Current Leases registered a high of $61,229 during FY2025, and its lowest value of $58,089 during FY2023.
- Moreover, its 3-year median value for Current Leases was $58,310 (2024), whereas its average is $59,209.
- Per our database at Business Quant, China SXT Pharmaceuticals' Current Leases decreased by 0.38% in 2024 and then rose by 5.01% in 2025.
- MRY analysis of 3 years shows China SXT Pharmaceuticals' Current Leases stood at $58,089 in 2023, then increased by 0.38% to $58,310 in 2024, then increased by 5.01% to $61,229 in 2025.
- Its Current Leases was $61,229 in FY2025, compared to $58,310 in FY2024 and $58,089 in FY2023.